JPRN-jRCTs051210204招募中2 期
An open-label, parallel-group exploratory study of the efficacy of anti-VEGF drugs for severe retinopathy of prematurity
eda Kaori0 个研究点目标入组 34 人开始时间: 2022年4月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 34
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •(1) Infants who are judged to require therapeutic intervention as severe retinopathy of prematurity based on the ETROP study.
- •1.zoneI, any stage ROP with plus disease
- •2.zoneII, stage3 ROP without plus disease
- •3.zoneII, stage2 or 3 ROP with plus disease
- •(2) Infants who have obtained consent from their parents to participate in the study for both eyes.
排除标准
- •(1) Infants who are in poor general condition and cannot undergo ophthalmologic examination
- •(2) Infants with eye infections
- •(3) Infants who are judged to be best treated with laser therapy at the time of initial treatment
- •(4) Infants who are judged to be inappropriate for participation in clinical research
研究者
相似试验
尚未招募
不适用
An open-label, parallel group study to explore the pharmacokinetics of eribulin (E7389) in patients with advanced solid tumors and normal or reduced hepatic function according to the Child Pugh system.Drug metabolism10027656CancerNL-OMON33939Eisai18
招募中
不适用
Efficacy of oral Ninjin'yoeito for improvement of fatigability and nutritional status in the perioperative period of primary lung cancerPrimary lung cancerprimary lung cance, non-small cell lung cancer, small cell lung cancerD002289, D055752JPRN-jRCT1031210136Ishibashi Hironori332
进行中（未招募）
不适用
A Study of RoActemra/Actemra (Tocilizumab) Versus Adalimumab in Combination With Methotrexate in Patients With Moderate to Severe Active Rheumatoid Arthritis And an Inadequate Response to Treatment With Only One TNF-InhibitorEUCTR2010-023587-40-SEF. Hoffmann-La Roche Ltd.96
尚未招募
不适用
Efficacy of oral Ninjin'yoeito for improvement of fatigability and nutritional status in the perioperative period of primary lung cancerung cancerJPRN-UMIN000042853Tokyo Medical and Dental University200
进行中（未招募）
不适用
A Open-Label, Parallel-Group, Exploratory Study to Evaluate the Efficacy and Safety of 400 µg Regadenoson Bolus for Pharmacological Stress EchocardiographySuspected coronary artery diseaseMedDRA version: 9.1Level: LLTClassification code 10011078Term: Coronary artery diseaseEUCTR2008-003839-20-GBGilead Sciences, Inc.